Bleepa achieves CE Mark - Raising the bar for medical communication platforms


As of 14 January 2022

The Company’s issued share capital at the above date was 2,666,931,677 ordinary shares of 0.25 pence each. The percentage of shares not held in public hands and insofar as the Company is aware (as defined by AIM rule 26) was 68.01%.

Shareholders with more than 3% holding were:

Shareholder Total Interest % issued shared capital
Unicorn Asset Management Limited 485,714,290 18.21%
Octopus Investments Nominees Limited 340,000,000 12.75%
Premier Miton Group PLC 253,333,332 9.5%
Mole Valley Asset Management Ltd 142,980,649 5.36%
Thomas Charlton 117,974,351 4.42%

The Directors who hold shares are:

Director Total Interest % issued shared capital
Prof. Rory Shaw 11,260,639 0.42%
Philipp Prince 4,046,543 0.15%
Adam Denning 2,958,981 0.11%